Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Cameron Winklevoss Critiques SEC's Bitcoin ETF Policy
  2. Markets Attempt A Rebound
  3. Markets Cheer U.S. GDP Data While Waiting For Jackson Hole Cues
  4. SEC Ordered to Review Grayscale's Bitcoin ETF Bid by Appeals Court
  5. Analytics Firm Santiment Highlights Market Fear as Potential Bitcoin Rebound Indicator